Key facts
- It has raised $13.7M; the latest was Later Stage VC ($13.7M) in Jan 2025.
- Notable investors include Tsing Stone Asset Management, Lotus Lake Ventures, Lingyi Capital, Zhongying Venture Capital, Sunland Fund — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for AINNOVI
- ·The full record, as it builds
Funding rounds
No funding rounds for AINNOVI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AINNOVI
Manufacturer of advanced medical imaging solutions aims to lead the refinement of visual imaging technologies for surgical applications. The company's offerings feature ultra-high-definition 3D vision systems, intelligent human-computer interaction technologies, and computational imaging-based digital surgical solutions, helping hospitals and surgeons improve surgical precision, reduce operation time, and enhance teaching and patient recovery outcomes, enabling global adoption of next-generation medical imaging.
- Sector
- Healthcare
- HQ
- Jiaxing, China
- Founded
- 2020
- Website
- ainnovi.com/
- Ownership
- Privately Held (backing)
AINNOVI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AINNOVI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AINNOVI in its N-PORT filings yet. We sweep new filings monthly.